These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24372696)

  • 1. Flow cytometry assessment of graft-infiltrating lymphocytes can accurately identify acute rejection in kidney transplants.
    Xavier PD; Lema GL; Magalhães MC; Teixeira-Pinto A; Sampaio-Norton S; Gaião S; Guimarães T; Oliveira JG
    Clin Transplant; 2014 Feb; 28(2):177-83. PubMed ID: 24372696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microemulsion cyclosporin formulation, in contrast to the old formulation, widens the T lymphocyte subsets differences between stable and acute rejection of kidney transplants.
    Oliveira JG; Ramos JP; Xavier P; Sampaio S; Magalhães MC; Mendes AA; Pestana M
    Nephrol Dial Transplant; 2001 Jun; 16(6):1256-61. PubMed ID: 11390729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.
    He J; Li Y; Zhang H; Wei X; Zheng H; Xu C; Bao X; Yuan X; Hou J
    Clin Transplant; 2013; 27(4):E351-8. PubMed ID: 23682828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of fine-needle aspiration biopsies by flow cytometry in kidney transplant patients.
    Oliveira JG; Ramos JP; Xavier P; Magalhães MC; Mendes AA; Guerra LE
    Transplantation; 1997 Jul; 64(1):97-102. PubMed ID: 9233708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.
    Vondran FW; Timrott K; Kollrich S; Steinhoff AK; Kaltenborn A; Schrem H; Klempnauer J; Lehner F; Schwinzer R
    Clin Transplant; 2014 Sep; 28(9):968-79. PubMed ID: 24931031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulation blockade with belatacept in renal transplantation.
    Vincenti F; Larsen C; Durrbach A; Wekerle T; Nashan B; Blancho G; Lang P; Grinyo J; Halloran PF; Solez K; Hagerty D; Levy E; Zhou W; Natarajan K; Charpentier B;
    N Engl J Med; 2005 Aug; 353(8):770-81. PubMed ID: 16120857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical assessment and determinants of chronic allograft nephropathy in maintenance renal transplant patients.
    Grinyo JM; Saval N; Campistol JM;
    Nephrol Dial Transplant; 2011 Nov; 26(11):3750-5. PubMed ID: 21474575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine versus everolimus: effects on the glomerulus.
    Baas MC; Kers J; Florquin S; de Fijter JW; van der Heide JJ; van den Bergh Weerman MA; ten Berge IJ; Bemelman FJ
    Clin Transplant; 2013; 27(4):535-40. PubMed ID: 23795805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients.
    Dresske B; Haendschke F; Lenz P; Ungefroren H; Jenisch S; Exner B; El Mokhtari NE; Lu T; Zavazava N; Faendrich F
    Transplantation; 2006 Jun; 81(11):1549-57. PubMed ID: 16770244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine needle aspiration biopsy in monitoring human renal transplant.
    Sirpal YM
    Indian J Pathol Microbiol; 1995 Oct; 38(4):393-7. PubMed ID: 9726150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
    Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
    Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients.
    Wang XZ; Jin ZK; Tian XH; Xue WJ; Tian PX; Ding XM; Zheng J; Li Y; Jing X; Luo ZZ
    Transpl Immunol; 2014 Jan; 30(1):18-23. PubMed ID: 24211610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class I (ABC) upregulation on peripheral blood CD3+/CD8+ T lymphocyte surface is a potential predictor of acute rejection in renal transplantation.
    Tian J; Shi WF; Zhang LW; Lu N; Cui XQ; Xian WH; Sun HB; Li EG; Geng LN; Zhang DZ; Zou X
    Transplantation; 2009 Dec; 88(12):1393-7. PubMed ID: 20029336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D
    J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation.
    Boleslawski E; BenOthman S; Grabar S; Correia L; Podevin P; Chouzenoux S; Soubrane O; Calmus Y; Conti F
    Clin Transplant; 2008; 22(4):494-501. PubMed ID: 18565100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.
    Moscarelli L; Caroti L; Antognoli G; Zanazzi M; Di Maria L; Carta P; Minetti E
    Clin Transplant; 2013; 27(4):546-54. PubMed ID: 23758330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
    Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
    Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
    J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.